Contents
Infections are the” good old enemy ” of man. We have lived side by side with pathogenic microorganisms throughout our history, and of course, in the process of evolution, we have managed to develop a certain protective mechanism. In medicine, it is called the immune system.
Of course, the reader may object, they say, we are not strong against infectious diseases with a single immunity today! There are, for example, vaccines and pharmacological preparations! Yes, there is. But here you need to understand that vaccination is not a treatment for infection, but prevention. If a person has already fallen ill, for example, with tuberculosis, then the BCG vaccination, made after that, will not help him in any way. Vaccines only prepare our bodies to meet certain types of disease-causing viruses or bacteria. Well, strictly speaking, vaccination is not a specific medicine, but only a way to “train” the immune system, and then he will have to cope with the infection that has entered the body all on his own.
What about pharmacology?
Yes, here humanity has made, let’s not be afraid of a big word, a real breakthrough. This, of course, is about the discovery of antibiotics. For some time after their active introduction into widespread practice, there was even a certain euphoria in the medical world. It seemed that we had confidently defeated one of our most terrible enemies-infectious diseases, which complicated almost every surgical operation and periodically caused global, all-planetary pandemics with millions of victims.
However, it quickly became clear that nature has many more surprises. Two of them turned out to be the most unpleasant for us:
- First, it turned out that antibiotics work well against bacteria, but are completely useless against viruses. That is, a good half of infectious diseases still loom before us as a constant threat, and the COVID-19 pandemic has clearly demonstrated this. And specific antiviral drugs, even at the moment, humanity has very little. We are able to treat hepatitis B and C viruses, herpes virus and cytomegalovirus. We are also able to inhibit the active reproduction of retroviruses, such as the human immunodeficiency virus. That’s probably all. The remaining antiviral agents are either still in the testing phase with vague prospects, or do not have confirmed effectiveness.
- Secondly, it turned out that bacteria are able and like to mutate – to change their genetic code so as to develop resistance to certain antibiotics. Of course, they do not do this purposefully, but the theory of evolution plays on their side – this process is in exact accordance with the laws of natural selection. And today we have a kind of “arms race”: pharmacologists create new drugs-antibiotics, and bacteria learn to resist them. The good news is that we still have the lead in this race. Bad news: this will only last as long as we develop new drug formulas faster than the microorganisms get protection from them.
How does the immune system work?
Immunity is a universal defense system that each of us has. It is an exceptionally complex and multicomponent structure with several main links:
- Cellular immunity. It is so called because it is based on whole living cells: macrophages, neutrophils, monocytes, different types of lymphocytes (for example, T-killers) and many others. The mechanisms of interaction of all this cellular ” zoo “are very complex, but the result of its work is always the same-the search and destruction of any “uninvited guests”, including pathogenic microorganisms.
- Humoral, or” molecular ” immunity. Here, the protective role is played not by whole cells, but by individual biochemical substances, complex molecules. They are also divided into two subtypes:
- Specific protection, which is represented by immunoglobulins (also called antibodies). This protection is specific because a certain type of antibody is produced in response to a strictly defined, “specific” infection. That is, immunoglobulins that can destroy, for example, Mycobacterium tuberculosis, will be useless against the notorious coronavirus SARS-CoV-2.
- Non-specific protection. It includes substances that have a common, but not so pronounced toxicity for many types of microorganisms at once. Such substances are interferons, lysozyme, transferrin and some other compounds.
The immune system is able to resist almost any infectious agents quite effectively. But it has a drawback – it needs time to “swing”. And the SARS-CoV-2 coronavirus that causes COVID-19, which we have already mentioned, will serve as a good example to demonstrate this disadvantage in a practical example:
- Our immune system “catches” the coronavirus almost immediately after it enters the body. And from this moment, the development of the immune response begins.
- There are still few viral bodies, and the patient has no clinical manifestations, but his immune defense already knows about the “invasion” and begins to counteract it.
- First, the non-specific link of humoral immunity enters the battle. But with a massive infection, its activity is usually not enough – the virus continues to multiply at a faster pace.
- The cellular link is focused primarily on the suppression of bacterial infections, the virus is too small a target for relatively large immune cells. Yes, they are able to destroy human cells already infected with the virus, but, unfortunately, this measure is also not able to stop the development of infection.
- All hope now is for a specific humoral immunity. Will he have time to find the formula and produce enough immunoglobulins that are” sharpened ” specifically for the destruction of the SARS-CoV-2 coronavirus?
The last point is the most important for understanding how the disease develops and how to resist it. The rapid multiplication of the virus and the defeat of all new cells leads to the appearance of clinical symptoms of COVID-19. And if the immune system has not yet developed enough specific antibodies, then the patient’s condition worsens. And so all the efforts of doctors that we hear about every day on TV today, all the treatment methods (maintenance therapy, then oxygen supply, then transfer to artificial respiration, etc.)-they all have one single goal. This goal is to buy a little more time for the patient’s immunity to create a “chemical weapon” against the coronavirus in the right volumes.
From all of the above, it becomes obvious that the more active the immune system is at the time of penetration of the virus into the body, the faster it will create the necessary immunoglobulins and produce them in an amount sufficient to suppress the infection. And this, in turn, is the main condition for preventing the severe course of the disease and the appearance of complications.
Therefore, it would be nice to somehow stimulate our immune system, make sure that it is always “in good shape”. It is this stimulating and tonic effect that the SibXP complex has due to the plant-derived polyprenols contained in it.
What parts of the immune system are affected by SibXP complex polyprenols?
On all of which we talked about above:
- It has been experimentally proven that taking polyprenols leads to the fact that macrophages, phagocytes and other immune cells begin to multiply faster, move faster through tissues and absorb foreign particles faster.
- Interferons of non-specific humoral immunity are substances belonging to the class of glycoproteins. And polyprenols are a biochemical substrate for the synthesis of these same glycoproteins (any, not only interferon).
- Immunoglobulins of specific humoral immunity are also, as it turned out, glycoproteins and a large amount of the same substrate is needed to accelerate their production.
- Finally, both antibodies and interferons do not arise by themselves – they are produced by certain types of cells. And the increased influx of polyprenols stimulates the reproduction of these cells. Well, then the direct math works: more “factories” for the manufacture of immunity components – stronger and stronger our immune defense as a whole.
It is important to emphasize another property of SibXP polyprenols as an immune stimulator – they are universal. That is, their maintenance of the tone of the immune system works equally well without reference to the type of pathogens. Accordingly, the SibXP complex will be effective, as part of a comprehensive prevention, for any infectious diseases.
Where to buy products with plant polyprenols?
The leading position in the production of polyprenols in our country is occupied by the company VILAVI INT LTD. Its specialists have developed the author’s technology for obtaining the SibXP complex, the active formula of which, in addition to polyprenols, also includes coniferous paste CGNC and fir cell juice. Today, on the basis of SibXP, VILAVI produces a whole line of delicious and healthy healthy food products. And in 2019, this invention was officially protected by a patent of the State Register of Inventions of the Russian Federation.